Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.39
  • Today's Change0.00 / 0.00%
  • Shares traded98.90k
  • 1 Year change+41.42%
  • Beta0.8249
Data delayed at least 10 minutes, as of Nov 01 2024 09:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (T14:SES) closed at 2.39, -10.15% below its 52-week high of 2.66, set on Jun 13, 2024.
52-week range
Today
1.66Feb 05 20242.66Jun 13 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open2.36
High2.39
Low2.33
Bid2.35
Offer2.39
Previous close2.39
Average volume78.08k
Shares outstanding770.16m
Free float424.78m
P/E (TTM)14.27
Market cap3.13bn USD
EPS (TTM)0.1675
USD
Annual div (ADY)0.1754
USD
Annual div yield (ADY)7.34%
Div ex-dateJul 02 2024
Div pay-dateJul 12 2024
Data delayed at least 10 minutes, as of Nov 01 2024 09:04 BST.
More ▼

Events & Activity

  • T14:SES price moved over -1.22% to 2.43
  • T14:SES trading volume exceeds daily average by +29.81%
  • T14:SES price falls below 15-day moving average to 2.41 at 02:31 BST
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.